Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20140212016557N6Phase 3Completed
Phase 3, single-blind trial of fluorouracil in common wart and Palmoplantar wart (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoint: Complete clinical cure. Started May 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20140212016557N6.